If you are having trouble viewing this email, view online version .

ESE News Alert - 19 November 2020

COVID-19 neurological complications associated with diabetes

New research suggests COVID-19 is associated with neurological complications such as brain bleeds and strokes, especially in patients with diabetes and hypertension.

Sky News 

New kisspeptin drug may improve fertility in women

According to a study published in the Journal of Clinical Investigation, a new drug called MVT-602 that targets the kisspeptin system may help improve fertility in women with reproductive conditions, such as polycystic ovary syndrome.

Science Daily

Diabetes diagnosis poses significant mental challenges

Many people diagnosed with diabetes find the psychological impact of managing the disease too challenging, a condition known as ‘diabetes burnout’.

BBC News

Computers may be able to identify congential adrenal hyperplasia

According to a study published in Jama Network Open, computers may be able to identify congential adrenal hyperplasia by analysing facial features and could help improve diagnosis and care of patients.

News Medical

Vitamin D may reduce advanced cancer risk

Vitamin D supplements may reduce the risk of developing advanced cancer by up to 17% and by 38% for those who are a healthy weight, according to a study published in Jama Network Open.

The Telegraph

The European Society of Endocrinology is Europe’s premier learned society promoting research, education and clinical practice in endocrinology for the public benefit and representing doctors and scientists who work in endocrinology. For more information, visit http://www.ese-hormones.org/

This news alert is designed to provide European Society of Endocrinology (ESE) members with a summary of stories on endocrinology currently appearing in the media. The views expressed in the stories featured in this update are not necessarily those of the ESE. The ESE accepts no responsibility for the accuracy or completeness of the material contained in this alert.

If you know of some European media coverage that would be of interest to the ESE membership, please contact the ESE press office.

Please note that the address that sent this email is not monitored and we cannot respond to direct replies.

Stay connected